For example, cetuximab targets HER1 (epidermal growth factor receptor, EGFR) and showed superior overall survival in recurrent/metastatic (r/m) HNSCC in combination with platinum-based chemotherapy [3]. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.